Wells Fargo’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Wells Fargo’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,333	Closed	-$759K	–	7770
2023 Q2	$759K	Buy	16,333 +9,856	+152%	+$341K	﹤0.01%	3649
2023 Q1	$186K	Buy	6,477 +6,465	+53,875%	+$191K	﹤0.01%	4478
2022 Q4	$374	Sell	12 -1,040	-99%	-$33.9K	﹤0.01%	6465
2022 Q3	$21K	Buy	1,052 +798	+314%	+$14.5K	﹤0.01%	5380
2022 Q2	$4K	Sell	254 -2,773	-92%	-$47.7K	﹤0.01%	6136
2022 Q1	$58K	Sell	3,027 -4,976	-62%	-$88.8K	﹤0.01%	5582
2021 Q4	$203K	Buy	+8,003	New	+$235K	﹤0.01%	5263

Wells Fargo's DICE Position: Q3 2023 in Review

Wells Fargo sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 16,333 shares — an estimated $759K sold.

Wells Fargo first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $759K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Wells Fargo reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Wells Fargo sold 16,333 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $759K.
Wells Fargo first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Wells Fargo's DICE Therapeutics, Inc. Common Stock position peaked at $759K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.